Neutrophil functions of patients with MPO-ANCA-related vasculitis

Internal Medicine

Volumn 42, Issue 7, 2003, Pages 552-553

  Suzuki, Kazuo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Activated neutrophils; Anti neutrophil cytoplasmic antibody (ANCA); MPO ANCA; Myeloperoxidase (MPO); Vasculitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CELL GRANULE; CELL NUCLEUS; CYTOPLASM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EDITORIAL; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENE MUTATION; HUMAN; LEUKOCYTE FUNCTION; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; SMALL VESSEL VASCULITIS; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0042672747     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.552     Document Type: Editorial

References (15)

1. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc γ receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-3195, 1995.
2. Minoshima S, Arimura Y, Nakabayashi K, et al. Increased release of myeloperoxidase in vitro from neutrophils of patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis. Nephrology 3: 527-534, 1997.
3. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91: 1-12, 1993.
4. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 15: 517-529, 1990.
5. Takii Y, Inoue H, Karashima E, et al. Systemic vasculitis associated with α1-antitrypsin deficiency. Intern Med 42: 619-623, 2003.
6. Ishida-Okawara A, Oharaseki T, Takahashi K, et al. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production. Inflammation 25: 381-387, 2001.
7. Yashiro M, Muso E, Itoh-Ihara T, et al. Significant high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis 35: 889-895, 2000.
8. Savage CO, Winearls CG, Jones SJ, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1: 1389-1393, 1987.
9. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13: 48-55, 2001.
10. Nunoi H, Kohi F, Kajiwara H, Suzuki K. Prevalence of Inherited Myeloperoxidase Deficiency in Japan. Microbiol Immunol in press.
11. Aratani Y, Koyama M, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828-1836, 1999.
12. Lehrer RL, Cline MJ. Leukocyte myeloperoxidase deficiency and desseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48: 1478-1488, 1969.
13. - production of neutrophis and vascular lesions in gammma globulin therapy of Kawasaki disease, Shulman ST, Ed. in: Progress in Clinical and Biological Research Alan R. Liss Inc, New York, 1987: 557-558.
14. Kettritz R, Schreiber A, Luft FC, Haller H. Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12: 37-46, 2001.
15. Murata H, Iijima H, Naoe S, Atobe T, Uchiyama T, Arakawa S. The pathogenesis of experimental arteritis induced by Candida alkali-extract in mice. Jpn J Exp Med 57: 305-313, 1987.